Global Renal Panel Testing Market, By Type of Product (Dipsticks, Reagents, and Disposables), Type of Test (Urine Tests, Blood Tests, Kidney Biopsy, Imaging Tests, Dilution and Concentration Tests, Clearance Tests, and Other Tests), End User (Hospitals, Clinics, Diagnostic Laboratories, Research Institutes, Ambulatory Surgical Centres, and Others) – Industry Trends and Forecast to 2030.
Renal Panel Testing Market Analysis and Size
Research development is a major driver accelerating the growth of the global kidney/renal function test market. Doctors and healthcare professionals constantly strive to introduce technologically advanced solutions to overcome various challenges. Some of the prominent key players are focusing on introducing some of the innovative research development activities, which are expected to form a robust footprint in the healthcare sector. The occurrence of functional damage to kidneys is increasing at a rapid rate. Excessive alcohol consumption, high blood pressure, hypertension, diabetes blood in urine, and difficulty in urination are some of the factors that increase chronic kidney disease. The high incidence of chronic kidney diseases and demand for efficient diagnosis of kidney diseases are expected to boost the adoption of the kidney/renal function test.
Moreover, with the rise in government initiatives to promote renal function tests to reduce the risks by detecting symptoms in the initial stages of the disorder, the market size for renal function tests may expand in the upcoming years. Medtech advancements by private medical institutions have made renal assessments more feasible and accessible to patients dealing with renal problems, owing to which market growth is anticipated.
Data Bridge Market Research analyses that the global renal panel testing market which was USD 845.36 million in 2022, and would rocket up to USD 1,598.61 million by 2030, and is expected to undergo a CAGR of 7.2% during the forecast period. This indicates that the market value. “Hospitals” dominates the end user segment of the renal panel testing market owing to the wide range of product applications in the hospitals. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Renal Panel Testing Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015-2020)
Revenue in USD Million, Volumes in Units, Pricing in USD
Type of Product (Dipsticks, Reagents, and Disposables), Type of Test (Urine Tests, Blood Tests, Kidney Biopsy, Imaging Tests, Dilution and Concentration Tests, Clearance Tests, and Other Tests), End User (Hospitals, Clinics, Diagnostic Laboratories, Research Institutes, Ambulatory Surgical Centres, and Others)
U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Rest of Middle East and Africa
Market Players Covered
Abbott (U.S.), Akers Biosciences, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Home Access Health (U.S.), Laboratory Corporation of America Holdings (U.S.), PRIMA Lab SA (Switzerland), Quest Diagnostics Incorporated (U.S.), Randox Laboratories Ltd. (U.K.), Sekisui Diagnostics (U.S.), Siemens (Germany), Merck KGaA (Germany), among others
The renal panel is known as a screening tool for understanding kidney function with known risk factors such as hypertension, diabetes, obesity, and family history of kidney disease. Also, the renal panel test helps to identify levels of various substances, including several minerals, electrolytes, proteins, and glucose (sugar), in the blood. This renal panel test helps to detect and diagnose kidney related problems.
Global Renal Panel Testing Market Dynamics
- Rise in The Prevalence of Diseases
The surging prevalence of chronic diseases all around the globe is one of the major factors responsible for fostering growth in the market value. The growing number of surgical procedures, rising awareness about the benefits of robotically assisted medical surgeries and surging number of road accidents are all responsible for boosting the market growth rate.
- Research and Development Proficiencies
Rising expenditure for research and development proficiencies, especially in the developed and developing economies pertaining to medical instruments and devices, will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in healthcare facilities is also bolstering the market growth rate.
- Growing Investment for Healthcare Facilities
Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering the growth of the market. The rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
- Expansion of the Medical Devices Industry
The medical devices industry is experiencing growth due to various factors, including advancements in device development, increasing investments in research and development, and expanding healthcare infrastructure. This growth directly impacts the Renal Panel Testing market.
- Government Investments in Healthcare Infrastructure
The increase in funding by the federal government is set to drive the market growth rate. Moreover, the growth and expansion of the healthcare industry being driven by both public and private players, especially in developing economies, will create lucrative market growth opportunities. Also, the high return on investments assured by the research activities will work in the favor of the market.
- High Cost Associated with Drug Development and Distribution
On the other hand, the cost of drug development and its distribution is very high in the market. Healthcare systems and payers face cost pressures, and there is a growing demand for cost-effective solutions. Manufacturers need to balance the development of innovative implants with affordability to meet market demands. This is expected to hinder the growth of the renal panel testing market, as healthcare providers may be reluctant to allocate funds for such non-essential equipment.
This renal panel testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the renal panel testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In July 2021, Roche developed the cobas c 501 and cobas e 601 systems, which are used for renal panel testing. These automated systems provide comprehensive testing for kidney function, including markers such as creatinine, urea, and electrolytes. Roche continues to improve and update its renal panel testing solutions to enhance accuracy and efficiency
- In August 2021, Abbott Laboratories will offer the ARCHITECT c8000 system, which includes tests for renal function assessment. The system provides a broad range of tests, including creatinine, urea, and electrolyte measurements, to evaluate kidney health. Abbott continues to invest in research and development to improve renal panel testing capabilities
Global Renal Panel Testing Market Scope
The renal panel testing market is segmented on the basis of product type, type of test and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type of Product
Type of Test
- Urine Tests
- Blood Tests
- Kidney Biopsy
- Imaging Tests
- Dilution and Concentration Tests
- Clearance Tests
- Other Tests
- Diagnostic Laboratories
- Research Institutes
- Ambulatory Surgical Centres
Global Renal Panel Testing Market Regional Analysis/Insights
The global renal panel testing market is analysed and market size insights and trends are provided by country, product type, type of test and end user as referenced above.
The countries covered in the global renal panel testing market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Rest of Middle East and Africa.
North America dominates the global renal panel testing market because of the strong base of healthcare facilities, strong presence of major players in the market, and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global renal panel testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the global renal panel testing market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the biomaterials market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Renal Panel Testing Market Share Analysis
The global renal panel testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to global renal panel testing market.
Some of the major players operating in the global renal panel testing market are:
- Abbott (U.S.)
- Akers Biosciences, Inc. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Boston Heart Diagnostics Corporation (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Home Access Health (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- PRIMA Lab SA (Switzerland)
- Quest Diagnostics Incorporated (U.S.)
- Randox Laboratories Ltd. (U.K.)
- Sekisui Diagnostics (U.S.)
- Siemens (Germany)
- Merck KGaA (Germany)